Hacer Demir

14PUBLICATIONS
141CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Feb 21, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

|Feb 13, 2026
Prognostic Value of the Lung Immune Prognostic Index (LIPI) in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study.

Beyza Ünlü, Hacer Demir, Sena Ece Davarcı

|Jan 24, 2026
Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy.

İsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay

|Nov 24, 2025
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways.

Yusuf Ilhan, Murat Araz, Ali Fuat Gurbuz

|Nov 12, 2025
Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?

Yaşar Culha, Beyza Ünlü, Sena Ece Davarcı

Pageof 3

Frequent Collaborators

6 joint publications

İsmail Beypınar

5 joint publications

Beyza Ünlü

5 joint publications

Meltem Baykara

5 joint publications

Murat Araz